Singapore vs Tunisia: New or unknown treatment history cases: Pulmonary, bacteriologically
Singapore
1,032
in 2023
Tunisia
932
in 2023
Singapore rank
109th
Tunisia rank
111th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Singapore
- Tunisia
How they compare
Singapore currently reports 1,032 against 932 in Tunisia, a difference of 100.
That makes Singapore's figure about 1.1 times Tunisia's.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was Singapore ahead.
Singapore ranks 109th and Tunisia ranks 111th of 197 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Singapore | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,116 | 1,032 | 83.71 | Singapore |
| 2020s | 1,058 | 880 | 177.5 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Singapore or Tunisia?
- Singapore, at 1,032 against 932 in Tunisia as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Singapore and Tunisia?
- 100, with Singapore ahead.
- How many years of comparable data are there for Singapore and Tunisia?
- 11 years are reported by both, from 2013 to 2023.
- How do Singapore and Tunisia rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Singapore ranks 109th and Tunisia ranks 111th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.